ea0099oc3.1 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024
van Zijverden Lieve
, Thijs Abel
, van Diemen Jeske
, Staphorsius Annemieke
, den Heijer Martin
, Wiepjes Chantal
Background: Transgender people often use gender-affirming hormone therapy to obtain physical characteristics that comply with their experienced gender. Transgender women use estradiol, usually with anti-androgens. Transgender men use testosterone. It has been reported that gender-affirming hormone therapy is associated with increased risk of acute cardiovascular events, however, this data constitutes largely of low quality evidence. We aimed to investigate the long-term incide...